Cytosorbents CTSO
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2026Q2 | 7.48 | -1 | -4 | -11.25 | 38 | |
| 2026Q1 | 11.33 | 2 | -126.69 | -5 | -12.1 | 41 |
| 2025Q4 | 12.78 | 6 | -73.67 | -5 | -12.22 | 44 |
| 2025Q3 | 18.68 | 9 | -30.77 | -3 | -6.76 | 46 |
| 2025Q2 | 25.6 | 12 | 14.91 | 2 | 3.94 | 48 |
| 2025Q1 | 20 | 15 | -11.52 | -1 | -3.01 | 51 |
| 2024Q4 | 18.2 | 11 | -62.78 | -8 | -15.9 | 47 |
| 2024Q3 | 30 | 13 | -16.49 | -2 | -4.84 | 48 |
| 2024Q2 | 14.06 | 17 | -24.74 | -4 | -8.78 | 53 |
| 2024Q1 | 19 | 19 | -30.13 | -6 | -12.67 | 47 |
| 2023Q4 | 22.2 | 23 | -27.93 | -6 | -11.57 | 53 |
| 2023Q3 | 37.6 | 19 | -43.16 | -9 | -18.38 | 48 |
| 2023Q2 | 71.8 | 24 | -23.2 | -6 | -11.2 | 52 |
| 2023Q1 | 67.4 | 29 | -22.78 | -7 | -12.14 | 57 |
| 2022Q4 | 31 | 35 | -2.06 | -1 | -1.22 | 63 |
| 2022Q3 | 27.2 | 39 | -28.14 | -12 | -18.28 | 62 |
| 2022Q2 | 43.8 | 48 | -21.13 | -11 | -14.08 | 71 |
| 2022Q1 | 63.8 | 55 | -15.2 | -9 | -10.38 | 83 |
| 2021Q4 | 83.8 | 63 | -13.98 | -9 | -10.08 | 90 |
| 2021Q3 | 162.4 | 71 | -8.84 | -6 | -6.63 | 95 |